We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Insulet said that it has acquired assets related to pump-based automated insulin delivery (AID) technologies from California-based medical technology start-up Bigfoot Biomedical for a price of $25m. The
Anavasi Diagnostics has secured an emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its AscencioDx COVID-19 Test and AscencioDx Molecular Detector. According to
GI Dynamics Inc., a medical device company that is developing the EndoBarrier System for patients diagnosed with type 2 diabetes and obesity, is pleased to announce the first
Nihon Kohden America, a provider of precision medical products and services, has launched the artificial intelligence (AI) powered CoMET tool, which has been built to provide early hints
Bausch + Lomb said that it has acquired AcuFocus, a California-based privately held ophthalmic medical device company, through one of its affiliates, for an undisclosed price. AcuFocus is
Cytovale has secured the US Food and Drug Administration (FDA) 510(k) clearance for its IntelliSep test to be used in the early detection of sepsis. IntelliSep is a
The efficacy of Novarad’s VisAR Augmented Reality Guidance system demonstrated an angular error of 1.3° (close to what can be achieved with a robot and below the 2°
Shockwave Medical, a US-based cardiovascular medical device company, has signed an agreement to acquire Neovasc, a speciality medical device company focused on the minimally invasive treatment of refractory
Accuray said that first patient treatments with its robotic radiation therapy delivery device CyberKnife System took place in New Zealand at the Auckland Radiation Oncology (ARO). The CyberKnife
Aegis Sciences Corporation, a health care testing laboratory based in Nashville, Tenn., today announced its acquisition of the HealthTrackRx Toxicology line of business. Aegis has provided science-driven drug